相关实验视频
Updated: Jun 24, 2026

09:40
Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
核细胞因子激活的IKKalpha通过抑制Maspin抑制前列腺癌转移来控制前列腺癌转移
Jun-Li Luo1, Wei Tan, Jill M Ricono
1Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology and Cancer Center, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0723, USA.
Nature
|March 23, 2007
概括
炎症通过激活IkappaB激酶α (IKKalpha) 来促进前列腺癌转移,该激酶α抑制Maspin转移抑制剂. 这一途径将炎症细胞与前列腺癌的进展和转移联系起来.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 已知炎症通过NF-kappaB通路促进瘤生长.
- NF-kappaB信号传递与上皮质-介质酶过渡和转移有关.
- 炎症和癌症转移之间的直接机械联系仍然难以捉摸.
研究的目的:
- 研究IkappaB激酶α (IKKalpha) 在前列腺癌进展和转移中的作用.
- 阐明炎症影响前列腺癌转移的分子机制.
主要方法:
- 使用TRAMP小鼠模型的前列腺癌.
- 研究了IKKalpha激活的作用及其对Maspin表达的下游影响.
- 在小鼠和人类前列腺癌样本中,与转移性进展相关的核IKKalpha水平.
主要成果:
- 抑制IKKalpha激活显著降低了TRAMP小鼠的前列腺癌生长和转移.
- 转移的减少与Maspin表达的增加相关;Maspin切除恢复了转移潜力.
- 激活RANKL的IKKalpha抑制了Maspin的表达,需要活性IKKalpha的核转位.
结论:
- 由瘤透RANKL表达的炎症细胞驱动的核IKKalpha激活抑制了Maspin转录.
- 这一途径通过抑制Maspin.png促进前列腺癌转移.
- 针对RANKL-IKKalpha-Maspin轴可能为前列腺癌转移提供治疗策略.
相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

